Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Mitomycin; Panitumumab
- Indications Anal cancer
- Focus Therapeutic Use
- 19 May 2016 Biomarkers information updated
- 07 May 2013 New trial record